文献速递外周动脉疾病

慢性肢体威胁性缺血保守治疗转归的系统综述与荟萃分析

Outcomes of Conservative Treatment in Patients with Chronic Limb Threatening Ischaemia: A Systematic Review and Meta-Analysis.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2021-03-03

汇总12个月全因死亡率为18%(95%CI 13-25),大截肢率为27%(95%CI 20-36),无截肢生存率为60%(95%CI 52-67)。保守治疗并非必然导致截肢或死亡,可用于共享决策。

要点

  • CLTI保守治疗12个月全因死亡率18%、大截肢率27%、无截肢生存率60%。
  • 多数纳入患者为不可重建的CLTI,研究质量中等。
  • 保守治疗可作为共享决策的一部分,并非必然导致截肢或死亡。

核心结论

  • CLTI保守治疗可以考虑,并不总是导致肢体丧失或患者死亡。
  • 本综述结果可用于在共享决策过程中告知患者保守治疗的转归。

研究设计与样本

  • 系统综述与荟萃分析,遵循PRISMA指南,检索MEDLINE、Embase和Cochrane Central自建库至2019年9月。
  • 多数研究纳入不可重建的CLTI患者,总体研究质量中等。

主要发现

  • 14项研究共755例患者,汇总1年大截肢率为27%(95%CI 20-36,I2=65%)。
  • 11项研究共970例患者,汇总12个月无截肢生存率为60%(95%CI 52-67,I2=75%)。

临床怎么用

  • 对于CLTI患者,保守治疗可作为共享决策的选项之一。
  • 可用本综述的转归数据向患者说明保守治疗的风险与获益。

局限性

  • 纳入研究多为观察性研究或随机临床试验安慰剂组,总体研究质量中等。
  • 多数研究纳入不可重建的CLTI患者,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Chronic limb threatening ischaemia (CLTI) is the most severe form of peripheral arterial disease. International guidelines recommend arterial revascularisation in patients with CLTI. However, these patients are often fragile elderly people with significant comorbidities, whose vascular anatomy is not always suitable for open or endovascular revascularisation. Recent studies have suggested acceptable outcomes of conservative treatment. A systematic review of the available literature was conducted to obtain best estimates of outcomes of conservative treatment in patients with CLTI. DATA SOURCES: MEDLINE, Embase, and Cochrane Central. REVIEW METHODS: A systematic review and meta-analysis was carried out following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. MEDLINE, Embase, and Cochrane Central were searched from inception until September 2019. All studies reporting on outcomes of conservative treatment for CLTI were considered. Study selection, data extraction, and risk of bias assessment were done by two investigators independently. Risk of bias was evaluated with a modified version of the Cochrane tool for observational studies. Outcomes of interest were all cause mortality, major amputation, and amputation free survival (AFS) after at least 12 months of follow up. A random effects model was used for meta-analyses. RESULTS: Twenty-seven publications were included, consisting of 12 observational studies and 15 placebo arms from randomised clinical trials, totalling 1 642 patients. Most studies included patients with non-reconstructable CLTI. Overall study quality was moderate. The pooled 12 month all cause mortality rate in 14 studies comprising 1 003 patients was 18% (95% confidence interval [CI] 13 - 25, I2 = 73%). The pooled major amputation rate from 14 studies comprising 755 patients was 27% (95% CI 20 - 36, I2 = 65%) after one year, and pooled AFS rate after 12 months in 11 studies with 970 patients was 60% (95% CI 52 - 67, I2 = 75%). CONCLUSION: Conservative treatment for patients with CLTI may be considered and does not always result in loss of limb or patient demise. The results of this review can be used to inform patients with CLTI about conservative treatment as part of a shared decision making process.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. van Reijen NS, Hensing T, Santema TKB, et al. Outcomes of Conservative Treatment in Patients with Chronic Limb Threatening Ischaemia: A Systematic Review and Meta-Analysis. Eur J Vasc Endovasc Surg. 2021. PMID: 33674157. doi:10.1016/j.ejvs.2021.01.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。